Revolutionizing Respiratory Care: How Qijia Medical's Easily Cough Device is Revolutionizing Patient Outcomes

Introduction

Respiratory conditions affect millions of individuals globally, particularly patients with neuromuscular diseases, chronic obstructive pulmonary disease (COPD), and post-operative recovery complications. Traditional airway clearance therapies most often prove inadequate to overcome stubborn secretions, leading to increased hospital stay and infection risk. That is where Qijia Medical's Easily Cough comes in—a revolutionary medical device that combines intelligent design and cutting-edge technology to transform respiratory treatment.

Key Breakthroughs That Drove the Easily Cough Revolution

1. Intelligent User Interface & Customizable Modes

The 8-inch HD touchscreen is no mere display, but a gateway to precision. Therapists can choose from manual, automatic, advanced, custom, and smart modes, tailoring therapy to patient-specific needs. For instance, the smart mode quantifies treatment in numbers, simplifying procedures and enhancing compliance—a feature tested in a 2023 trial at Shanghai Pulmonary Hospital, where nurse-documented efficiency improved by 40%.

2. Mechanical Insufflation-Exsufflation (MIE) Technology

At its core, Easily Cough employs MIE technology, simulating natural coughing through a dynamic pressure system:

· +40 cmH₂O positive pressure during inhalation opens airways and loosens secretions.

· -40 cmH₂O negative pressure during exhalation generates high-velocity airflow to expel mucus.

This two-stage approach has been endorsed by the European Respiratory Society as "critical for patients with compromised cough reflexes," such as those with ALS or spinal trauma.

3. Infection Control: A 99.9% Bacterial Kill Rate

Hospital-acquired infections (HAIs) are a global issue, costing the U.S. healthcare system $28 billion annually. Easily Cough's innovative disinfection circuit tackles this challenge head-on, achieving a ≥99.9% bacterial kill rate (tested against Staphylococcus aureus and Pseudomonas aeruginosa). At Germany's Charité Hospital, implementation of this system reduced ventilator-associated pneumonia (VAP) by 32% over six months.

4. Real-Time Monitoring & Data-Driven Care

The integrated SpO₂ and heart rate monitor provides real-time feedback, while the device stores 10 sets of Chinese-language treatment profiles—ideal for tracking progress across multiple departments. At Tokyo's Keio University Hospital, this feature enabled clinicians to refine secretion clearance protocols for pediatric cystic fibrosis patients, cutting ICU readmissions by 25%.

Global Case Studies: Evidence of Impact

Case 1: Post-Operative Recovery in Canada

45 patients at Toronto General Hospital who underwent thoracic surgery and used Easily Cough experienced:

· 50% faster mucus clearance compared to conventional chest physiotherapy.

· 20% shorter hospital stays.

Dr. Emily Carter observed, "The pressure differential technology prevented post-op atelectasis in high-risk patients—a feat manual methods couldn't consistently achieve."

Case 2: Care in Pediatric Brazil

São Paulo's Albert Einstein Hospital reported a 35% reduction in bronchial obstruction cases among children with cerebral palsy after adopting Easily Cough. The device's calming oscillatory action proved invaluable for non-verbal patients unable to coordinate voluntary coughing.

Why Clinicians Worldwide Are Prioritizing This Technology

Versatility Across Specialties

From ICUs to geriatric wards, Easily Cough is applicable in various departments:

· Neurology: Manages secretion retention in ALS patients.

· Oncology: Prevents pneumonia during chemotherapy-induced immunosuppression.

· Emergency Care: Clears airway obstructions in traumatic situations.

Cost-Effective Longevity

The high-seal control valve minimizes pressure loss over time—a common design flaw in competing devices. A UK NHS audit found Easily Cough units remained 95% effective after three years, versus 60–70% for conventional models.

Compliance with International Standards

The device is FDA (USA), CE (EU), and NMPA (China) compliant, with trials underway for WHO prequalification—a testament to its safety and efficacy.

Conclusion: The Future of Airway Management is Now

Qijia Medical's Easily Cough isn't just a device—it's a revolution. By merging clinical precision with infection-safe technology, it empowers medical staff to deliver superior respiratory care while reducing costs. As Dr. Hans Müller of Swiss University Hospital Basel states, "This is the first technology that truly mimics the physiology of a natural cough—it's revolutionizing our approach to airway hygiene."

For healthcare facilities aiming to optimize patient outcomes and operational efficiency, Easily Cough isn't just an option—it's a necessity.

Airway clearance system   cough assist device